Department of Physiology and Pharmacology, Center for the Neurobiology of Addiction and Treatment, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
J Neuroimmune Pharmacol. 2010 Mar;5(1):70-82. doi: 10.1007/s11481-009-9189-8.
Until recently, knowledge of the impact of abused drugs on gene and protein expression in the brain was limited to less than 100 targets. With the advent of high-throughput genomic and proteomic techniques, investigators are now able to evaluate changes across the entire genome and across thousands of proteins in defined brain regions and generate expression profiles of vulnerable neuroanatomical substrates in rodent and nonhuman primate drug abuse models and in human post-mortem brain tissue from drug abuse victims. The availability of gene and protein expression profiles will continue to expand our understanding of the short- and long-term consequences of drug addiction and other addictive disorders and may provide new approaches or new targets for pharmacotherapeutic intervention. This review summarizes several important genomic and proteomic studies of cocaine abuse/addiction from rodent, nonhuman primate, and human postmortem studies of cocaine abuse and explores how these studies have advanced our understanding of addiction.
直到最近,人们对滥用药物对大脑中基因和蛋白质表达影响的了解还局限于不到 100 个靶点。随着高通量基因组和蛋白质组学技术的出现,研究人员现在能够评估整个基因组和数千种特定脑区蛋白质的变化,并在啮齿动物和非人灵长类药物滥用模型以及药物滥用受害者的人类死后脑组织中生成易损神经解剖基质的表达谱。基因和蛋白质表达谱的出现将继续加深我们对药物成瘾和其他成瘾障碍的短期和长期后果的理解,并可能为药物治疗干预提供新的方法或新的靶点。这篇综述总结了几项关于可卡因滥用/成瘾的重要基因组和蛋白质组学研究,这些研究来自于啮齿动物、非人灵长类动物和可卡因滥用的人类死后研究,并探讨了这些研究如何增进我们对成瘾的理解。